Drug Candidate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

♪ ♪ ♪ ♪. rachel: it is christmas time that is christina aguilera. look at the box christmas tree that is up and bright and attracting tourist from all over the country for their christmas photos and we are here it is 7:00 a.m. i am with will and pete will is jazzed up about sports he has not stopped working to keep going, are you going to keep going on sports? will: i don't want to wear everybody out. i'm a partisan and i'm right i'm a partisan. pete: i'm worn out. i reached the depth of my knowledge. will: you want to pick a fight you been trying but i win in the green room....

Chris Alexander, the former head of the New York Office of Cannabis Management (OCM), resigned in May. Gov. Kathy Hochul first announced that Alexander's contract would not be renewed following its end in September. As Green Market Report's John Schroyer highlighted, the governor on Monday announced three new experts to lead the agency.S3 Collective has formed its governmental advisory committee (GAC).

Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Marinus Pharmaceuticals, Inc. securities between March...

Ewopharma acquired marketing rights for namodenoson in the treatment of pancreatic carcinoma ...

When you’re looking for a stock sector with potential for big gains, you can’t help but look at the biotechs. These stocks are famous for their long product lead times and high overhead – bringing a new pharmaceutical to market can take years, and cost tens of millions of dollars – but for investors, their attraction lies in their potential. One piece of good news, be it a positive clinical trial result or meeting a regulatory milestone, can give a major boost to the share price. The trick is fi